CF gene carriers may face hidden organ risks
NCT ID NCT05474417
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether people who carry one copy of the cystic fibrosis gene (CF carriers) have early signs of kidney or pancreas problems. Researchers will compare 1250 CF carriers and non-carriers using blood tests, urine and stool samples, and surveys. The goal is to see if carriers have higher risks for conditions like diabetes or kidney disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study finds clear links, it could lead to earlier monitoring or preventive care for CF carriers at risk of kidney or pancreas problems.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not find strong evidence, and results may not apply to all CF carriers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARRIER STATE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Iowa Hospitals and Clinics
RECRUITINGIowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Contrast dye Double-Dose: new study tracks kidney fallout in ICU patients
- Probiotics join the fight against superbugs in the gut
- Could a simple breath test spot hidden diseases early?
- Steroids for kidney disease: do they prevent failure Long-Term?
- Could a simple hand soak reveal cystic fibrosis risk?
- New drug shows promise for kidney disease patients